Florida is one of several states that have sought to protect newborns by requiring that mothers known to have used alcohol or illicit drugs during pregnancy be reported to health authorities. To estimate the prevalence of substance abuse by pregnant women, we collected urine samples from all pregnant women who enrolled for prenatal care at any of the five public health clinics in Pinellas County, Florida (n = 380), or at any of 12 private obstetrical offices in the county (n = 335); each center was studied for a one-month period during the first half of 1989. Toxicologic screening for alcohol, opiates, cocaine and its metabolites, and cannabinoids was performed blindly with the use of an enzyme-multiplied immunoassay technique; all positive results were confirmed. Among the 715 pregnant women we screened, the overall prevalence of a positive result on the toxicologic tests of urine was 14.8 percent; there was little difference in prevalence between the women seen at the public clinics (16.3 percent) and those seen at the private offices (13.1 percent). The frequency of a positive result was also similar among white women (15.4 percent) and black women (14.1 percent). Black women more frequently had evidence of cocaine use (7.5 percent vs. 1.8 percent for white women), whereas white women more frequently had evidence of the use of cannabinoids (14.4 percent vs. 6.0 percent for black women). During the six-month period in which we collected the urine samples, 133 women in Pinellas County were reported to health authorities after delivery for substance abuse during pregnancy. Despite the similar rates of substance abuse among black and white women in our study, black women were reported at approximately 10 times the rate for white women (P less than 0.0001), and poor women were more likely than others to be reported. We conclude that the use of illicit drugs is common among pregnant women regardless of race and socio-economic status. If legally mandated reporting is to be free of racial or economic bias, it must be based on objective medical criteria.
Source Information
Northwestern University Medical School, Chicago, IL.
This article has been cited by other articles:
Yonkers, K. A.
(2009). Parsing Risk for the Use of Selective Serotonin Reuptake Inhibitors in Pregnancy. Am. J. Psychiatry
166: 268-270
[Full Text]
Keyes, K. M., Hatzenbuehler, M. L., Alberti, P., Narrow, W. E., Grant, B. F., Hasin, D. S.
(2008). Service Utilization Differences for Axis I Psychiatric and Substance Use Disorders Between White and Black Adults. Psychiatr. Serv.
59: 893-901
[Abstract][Full Text]
Terling Watt, T., McCoy Rogers, J.
(2007). Factors Contributing to Differences in Substance Use Among Black and White Adolescents. Youth Society
39: 54-74
[Abstract]
Brown, S. D., Truog, R. D., Johnson, J. A., Ecker, J. L.
(2006). Do Differences in the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists Positions on the Ethics of Maternal-Fetal Interventions Reflect Subtly Divergent Professional Sensitivities to Pregnant Women and Fetuses?. Pediatrics
117: 1382-1387
[Abstract][Full Text]
Halloran, D. R., Wall, T. C., Evans, H. H., Hardin, J. M., Woolley, A. L.
(2005). Hearing Screening at Well-Child Visits. Arch Pediatr Adolesc Med
159: 949-955
[Abstract][Full Text]
Eckenwiler, L.
(2004). Why Not Retribution? The Particularized Imagination and Justice for Pregnant Addicts. J Law Med Ethics
32: 89-99
Donohue, B.
(2004). Coexisting Child Neglect and Drug Abuse in Young Mothers: Specific Recommendations for Treatment Based on a Review of the Outcome Literature. Behav Modif
28: 206-233
[Abstract]
Eliason, M. J., Taylor, J. Y., Williams, R.
(2004). Physical Health of Women in Prison: Relationship to Oppression. J Correct Health Care
10: 175-203
[Abstract]
Chasnoff, I. J.
(2003). Prenatal Substance Exposure: Maternal Screening and Neonatal Identification and Management. NeoReviews
4: e228-235
[Full Text]
Chan, D., Klein, J., Koren, G.
(2003). New Methods for Neonatal Drug Screening. NeoReviews
4: e236-244
[Full Text]
JOHNSON, K., GERADA, C., GREENOUGH, A.
(2003). Substance misuse during pregnancy. Br. J. Psychiatry
183: 187-189
[Full Text]
Lau, A. S., McCabe, K. M., Yeh, M., Garland, A. F., Hough, R. L., Landsverk, J.
(2003). Race/Ethnicity and Rates of Self-Reported Maltreatment among High-Risk Youth in Public Sectors of Care. Child Maltreat
8: 183-194
[Abstract]
Lester, B. M., ElSohly, M., Wright, L. L., Smeriglio, V. L., Verter, J., Bauer, C. R., Shankaran, S., Bada, H. S., Walls, H. C., Huestis, M. A., Finnegan, L. P., Maza, P. L.
(2001). The Maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-Report. Pediatrics
107: 309-317
[Abstract][Full Text]
Ondersma, S. J., Simpson, S. M., Brestan, E. V., Ward, M.
(2000). Prenatal Drug Exposure and Social Policy: The Search for an Appropriate Response. Child Maltreat
5: 93-108
[Abstract]
Yu, R. C.-T., Lee, T.-C., Wang, T.C., Li, J.-H.
(1999). Genetic toxicity of cocaine. Carcinogenesis
20: 1193-1199
[Abstract][Full Text]
Wallace Jr, J. M.
(1999). The Social Ecology of Addiction: Race, Risk, and Resilience. Pediatrics
103: 1122-1127
[Abstract][Full Text]
Chasnoff, I. J.
(1998). Silent Violence: Is Prevention a Moral Obligation?. Pediatrics
102: 145-147
[Full Text]
Issari, P., Coombs, R. H.
(1998). WOMEN, DRUG USE, AND DRUG TESTING: The Case of the Intercollegiate Athlete. Journal of Sport and Social Issues
22: 153-169
[Abstract]
HUMPHRIES, D.
(1998). Crack Mothers at 6: Prime-Time News, Crack/Cocaine, and Women. Violence Against Women
4: 45-61
[Abstract]
MacMahon, J. R.
(1997). Perinatal Substance Abuse: The Impact of Reporting Infants to Child Protective Services. Pediatrics
100: e1-e1
[Abstract][Full Text]
Baraban, S. C., Schwartzkroin, P. A.
(1997). Effects of Prenatal Cocaine Exposure on the Developing Hippocampus: Intrinsic and Synaptic Physiology. J. Neurophysiol.
77: 126-136
[Abstract][Full Text]
Kwong, T. C., Ryan, R. M.
(1997). Detection of intrauterine illicit drug exposure by newborn drug testing. Clin. Chem.
43: 235-242
[Abstract][Full Text]
Grant, D.
(1996). Generalizability of Findings of Exploratory Practice-Based Research on Polydrug-Addicted Mothers. Research on Social Work Practice
6: 292-307
[Abstract]
Laraque, D., Mitchell, J.
(1996). A Matter of Trust: Mandatory HIV Testing. Arch Pediatr Adolesc Med
150: 556-557
[Abstract]
Berkowitz, G., Brindis, C., Clayson, Z.
(1996). Using a Multimethod Approach to Measure Success in Perinatal Drug Treatment. Eval Health Prof
19: 48-67
[Abstract]
Fretts, R. C., Schmittdiel, J., McLean, F. H., Usher, R. H., Goldman, M. B.
(1995). Increased Maternal Age and the Risk of Fetal Death. NEJM
333: 953-957
[Abstract][Full Text]
Barone, D.
(1995). "Be Very Careful Not to Let the Facts Get Mixed Up with the Truth": Children Prenatally Exposed to Crack/Cocaine. Urban Education
30: 40-55
[Abstract]
Farr, K. A.
(1995). Fetal Abuse and the Criminalization of Behavior During Pregnancy. Crime Delinquency
41: 235-245
[Abstract]
Lieberman, E.
(1995). Low Birth Weight -- Not a Black-and-White Issue. NEJM
332: 117-118
[Full Text]
Frassica, J. J., Orav, E. J., Walsh, E. P., Lipshultz, S. E.
(1994). Arrhythmias in Children Prenatally Exposed to Cocaine. Arch Pediatr Adolesc Med
148: 1163-1169
[Abstract]
Snodgrass, S. R.
(1994). Cocaine Babies: A Result of Multiple Teratogenic Influences. J Child Neurol
9: 227-233
[Abstract]
Yawn, B. P., Thompson, L. R., Lupo, V. R., Googins, M. K., Yawn, R. A.
(1994). Prenatal Drug Use in Minneapolis^St Paul, Minn: A 4-Year Trend. Arch Fam Med
3: 520-527
[Abstract]
Schroedel, J. R., Peretz, P.
(1994). A Gender Analysis of Policy Formation: The Case of Fetal Abuse. Journal of Health Politics, Policy and Law
19: 335-360
[Abstract]
Nair, P., Rothblum, S., Hebel, R.
(1994). Neonatal Outcome in Infants With Evidence of Fetal Exposure to Opiates, Cocaine, and Cannabinoids. CLIN PEDIATR
33: 280-285
[Abstract]
Neuspiel, D. R.
(1994). Infant 'Abandonment' by Drug-Using Mothers: Blaming the Victims?. Arch Pediatr Adolesc Med
148: 437-438
[Abstract]
Mason, E., Vega, W. A.
(1994). Perinatal Substance Exposures in California. NEJM
330: 794-794
[Full Text]
Barrett, M. E., Wong, F. Y., McKay, D. R. R.
(1993). Self-Reported Alcohol Use Among Women of Childbearing Age and Their Knowledge of Alcohol Warning Labels and Signs. Arch Fam Med
2: 1260-1264
[Abstract]
Racine, A., Joyce, T., Anderson, R.
(1993). The Association Between Prenatal Care and Birth Weight Among Women Exposed to Cocaine in New York City. JAMA
270: 1581-1586
[Abstract]
Vega, W. A., Kolody, B., Hwang, J., Noble, A.
(1993). Prevalence and Magnitude of Perinatal Substance Exposures in California. NEJM
329: 850-854
[Abstract][Full Text]
McNagny, S. E.
(1992). The Self-reporting of Cocaine Use-Reply. JAMA
268: 2375-2376
[Abstract]
Yawn, B. P., Yawn, R. A., Uden, D. L.
(1992). Substance Use in Rural Midwestern Pregnant Women. Arch Fam Med
1: 83-88
[Abstract]
Bernstein, S. L., Bristow, L. R., Clowe, J. L., Contogiannis, M. A., Greenville, , Corlin, R. F., Dickey, N. W., Formica, P. E., Brunswick, N., Jacott, W. E., Johnson, D. H. Jr, McAfee, R. E., Painter, J. T., Reardon, T. R., Ring, J. J., Scalettar, R., Schenken, J. R., Seward, J. P., Tupper, C. J., Walker, F. B., Wootton, P., Cason, D. K., Cheney, F. W., Denser, C. H. Jr, Grandon, R. C., Lieb, F. X., Martin, J. A., Ogrod, E. S. II, Orentlicher, D., Schweickart, A. K., Orentlicher, D.
(1992). Requirements or Incentives by Government for the Use of Long-Acting Contraceptives: Board of Trustees, American Medical Association. JAMA
267: 1818-1821
[Abstract]
McNagny, S. E., Parker, R. M.
(1992). High Prevalence of Recent Cocaine Use and the Unreliability of Patient Self-report in an Inner-city Walk-in Clinic. JAMA
267: 1106-1108
[Abstract]
Mayes, L. C., Granger, R. H., Bornstein, M. H., Zuckerman, B.
(1992). The Problem of Prenatal Cocaine Exposure: A Rush to Judgment. JAMA
267: 406-408
[Abstract]
Chavkin, W.
(1991). Mandatory Treatment for Drug Use During Pregnancy. JAMA
266: 1556-1561
[Abstract]
Chasnoff, I. J.
(1991). Drugs, Alcohol, Pregnancy, and the Neonate: Pay Now or Pay Later. JAMA
266: 1567-1568
[Abstract]
(1990). Legal Interventions During Pregnancy: Court-Ordered Medical Treatments and Legal Penalties for Potentially Harmful Behavior by Pregnant Women. JAMA
264: 2663-2670
[Abstract]